Arbutus Biopharma Corp. (ABUS)
5.20
-0.01
(-0.19%)
USD |
NASDAQ |
Aug 24, 16:00
5.20
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Total Assets (Quarterly) : 274.02M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 274.02M |
| March 31, 2026 | 277.16M |
| December 31, 2025 | 94.62M |
| September 30, 2025 | 97.71M |
| June 30, 2025 | 103.27M |
| March 31, 2025 | 117.01M |
| December 31, 2024 | 131.71M |
| September 30, 2024 | 140.44M |
| June 30, 2024 | 160.04M |
| March 31, 2024 | 150.29M |
| December 31, 2023 | 144.40M |
| September 30, 2023 | 158.64M |
| June 30, 2023 | 176.82M |
| March 31, 2023 | 191.22M |
| December 31, 2022 | 195.42M |
| September 30, 2022 | 203.80M |
| June 30, 2022 | 215.84M |
| March 31, 2022 | 236.88M |
| December 31, 2021 | 204.48M |
| September 30, 2021 | 165.60M |
| June 30, 2021 | 135.38M |
| March 31, 2021 | 146.24M |
| December 31, 2020 | 137.08M |
| September 30, 2020 | 131.10M |
| June 30, 2020 | 97.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 102.61M |
| December 31, 2019 | 105.54M |
| September 30, 2019 | 117.28M |
| June 30, 2019 | 192.57M |
| March 31, 2019 | 209.22M |
| December 31, 2018 | 227.90M |
| September 30, 2018 | 245.42M |
| June 30, 2018 | 277.01M |
| March 31, 2018 | 270.03M |
| December 31, 2017 | 237.16M |
| September 30, 2017 | 239.84M |
| June 30, 2017 | 255.08M |
| March 31, 2017 | 268.14M |
| December 31, 2016 | 275.92M |
| September 30, 2016 | 514.73M |
| June 30, 2016 | 530.86M |
| March 31, 2016 | 703.25M |
| December 31, 2015 | 712.29M |
| September 30, 2015 | 722.63M |
| June 30, 2015 | 773.82M |
| March 31, 2015 | 787.06M |
| December 31, 2014 | 118.18M |
| September 30, 2014 | 125.06M |
| June 30, 2014 | 132.07M |
| March 31, 2014 | 138.52M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Moderna, Inc. | 10.96B |
| Insmed, Inc. | 2.103B |
| Pfizer Inc. | 201.13B |
| Gossamer Bio, Inc. | 76.87M |
| Legend Biotech Corp. | 1.751B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.29M |
| Shareholders Equity (Quarterly) | 258.73M |
| Debt to Equity Ratio | 0.014 |
| Current Ratio | 81.42 |
| Net Debt Paydown Yield | 0.04% |